top of page
AI for Drug Discovery, Biomarker Development and
Advanced R&D Landscape Overview 2021
This Investment Digest is summarizing key players and observations in the private equity and venture capital ecosystem, focusing on the pharmaceutical Artificial Intelligence (AI).
Here we have presented the information about key industry trends, 300 promising AI-driven companies and 50 leading biotech investors in this sector, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors.
bottom of page